CMV neurologic disease: Difference between revisions
(Text replacement - "==Clinical Presentation==" to "==Clinical Features==") |
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
||
| Line 5: | Line 5: | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
== | ==Evaluation== | ||
==Management== | ==Management== | ||
Revision as of 20:48, 22 July 2016
Background
Clinical Features
Differential Diagnosis
Evaluation
Management
Antivirals
- Ganciclovir 5mg/kg IV q12hrs daily x 21 days FOLLOWED BY 5mg/kg IV q24hrs +
- Foscarnet 90mg/kg IV q12hrs x 21 days THEN 90-120mg/kg IV q24hrs